These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2807507)

  • 1. Growth hormone and diabetic retinopathy.
    Singh R; Agrawal JK; Kumar V; Raman RD; Maurya OP
    Indian J Ophthalmol; 1989; 37(1):5-7. PubMed ID: 2807507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema.
    Browning DJ; Fraser CM; Clark S
    Ophthalmology; 2008 Mar; 115(3):533-539.e2. PubMed ID: 18067962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endothelial dysfunction of central retinal vessels: a prognostic parameter for diabetic retinopathy?].
    Dawczynski J; Mandecka A; Blum M; Müller UA; Ach T; Strobel J
    Klin Monbl Augenheilkd; 2007 Nov; 224(11):827-31. PubMed ID: 18034395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretion of growth hormone in the insulin test, and the development of diabetic microangiopathy.
    Sieradzki J
    Pol Med Sci Hist Bull (1973); 1976; 15(2):191-6. PubMed ID: 959044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rarity of diabetic retinopathy in patients with acromegaly.
    Ballintine EJ; Foxman S; Gorden P; Roth J
    Arch Intern Med; 1981 Nov; 141(12):1625-7. PubMed ID: 7305571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occurrence of changes in the eye in diabetic retinopathy with significant myopia].
    Dujić M; Misailović K; Nikolić Lj; Ignjacev M
    Srp Arh Celok Lek; 1998; 126(11-12):457-60. PubMed ID: 9921019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of serum semicarbazide-sensitive amine oxidase activity in diabetic retinopathy in type-2 diabetes].
    Dura E; Mészáros Z; Salacz G; Magyar K; Romics L; Karádi I
    Orv Hetil; 2002 Nov; 143(47):2637-44. PubMed ID: 12532650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics with or without severe microvascular lesions.
    Blickle JF; Schlienger JL; de Laharpe F; Stephan F
    Diabete Metab; 1982 Sep; 8(3):197-201. PubMed ID: 6814964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-1 overexpression in nonproliferative diabetic retinopathy.
    Grant MB; Ellis EA; Caballero S; Mames RN
    Exp Eye Res; 1996 Sep; 63(3):233-44. PubMed ID: 8943696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII, von Willebrand factor and platelet adhesiveness in diabetic retinopathy.
    Nozaki H; Hiramatsu K; Arimori S
    Tokai J Exp Clin Med; 1987 Mar; 12(1):7-9. PubMed ID: 3130682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and diabetic retinopathy.
    Singh R; Agrawal JK; Kumar V; Raman RD
    Indian J Ophthalmol; 1983; 31 Suppl():1049-52. PubMed ID: 6544256
    [No Abstract]   [Full Text] [Related]  

  • 14. [Change of retinal oxygen saturation in healthy subjects and in early stages of diabetic retinopathy during breathing of 100% oxygen].
    Schweitzer D; Lasch A; van der Vorst S; Wildner K; Hammer M; Voigt U; Jütte M; Müller UA
    Klin Monbl Augenheilkd; 2007 May; 224(5):402-10. PubMed ID: 17516370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the natural course of diabetic retinopathy: a population-based study in Kinmen, Taiwan.
    Tung TH; Chen SJ; Shih HC; Chou P; Li AF; Shyong MP; Lee FL; Liu JH
    Ophthalmic Epidemiol; 2006 Oct; 13(5):327-33. PubMed ID: 17060111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlations between clinical findings and therapeutic measures and the course of diabetic retinopathy].
    Teuscher A
    Schweiz Med Wochenschr; 1976 Jul; 106(31):1041-5. PubMed ID: 996527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-proliferative diabetic retinopathy and red blood cell aggregation].
    Turczyński B; Michalska-Małecka K; Słowińska L; Szczesny S; Romaniuk W
    Wiad Lek; 2004; 57(11-12):634-40. PubMed ID: 15865241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa-stimulated growth hormone secretion and diabetic retinopathy.
    Holland PM; Landers MB; Lebovitz HE; Wolbarsht ML
    Am J Ophthalmol; 1976 Oct; 82(4):612-8. PubMed ID: 970425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Somatotropic hormone in the serum of diabetics].
    Dobrev D; Manolov D; Vakov L
    Vutr Boles; 1981; 20(2):49-53. PubMed ID: 7257332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H; Shi CH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.